McKinley Carter Wealth Services Inc. Has $271,000 Stock Holdings in CME Group Inc. $CME

McKinley Carter Wealth Services Inc. trimmed its position in shares of CME Group Inc. (NASDAQ:CME) by 12.9% during the second quarter, HoldingsChannel.com reports. The firm owned 982 shares of the financial services provider’s stock after selling 145 shares during the period. McKinley Carter Wealth Services Inc.’s holdings in CME Group were worth $271,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in CME. Heartland Bank & Trust Co acquired a new position in shares of CME Group in the first quarter worth approximately $377,000. Catalyst Capital Advisors LLC lifted its stake in shares of CME Group by 256.9% in the first quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider’s stock worth $971,000 after acquiring an additional 2,636 shares during the period. OMNI 360 Wealth Inc. acquired a new position in shares of CME Group in the first quarter worth approximately $367,000. Fulcrum Equity Management acquired a new position in shares of CME Group in the first quarter worth approximately $258,000. Finally, AIA Group Ltd lifted its stake in shares of CME Group by 17.8% in the first quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock worth $4,416,000 after acquiring an additional 2,510 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at CME Group

In other CME Group news, Director William R. Shepard acquired 262 shares of the stock in a transaction on Thursday, September 25th. The shares were purchased at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the completion of the acquisition, the director owned 258,459 shares in the company, valued at approximately $68,540,742.21. This represents a 0.10% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the sale, the general counsel owned 7,851 shares of the company’s stock, valued at $2,056,962. This trade represents a 4.76% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,043 shares of company stock worth $3,527,956. Corporate insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CME. Citigroup raised CME Group from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $275.00 to $300.00 in a research note on Thursday, September 25th. Morgan Stanley lifted their price objective on CME Group from $303.00 to $312.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 1st. JPMorgan Chase & Co. lifted their price objective on CME Group from $246.00 to $252.00 and gave the stock an “underweight” rating in a research note on Thursday, September 25th. Weiss Ratings reissued a “buy (b)” rating on shares of CME Group in a research note on Wednesday. Finally, Wall Street Zen lowered CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Seven investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $281.00.

CME Group Stock Performance

Shares of CME opened at $271.45 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a 50-day moving average of $268.89 and a 200-day moving average of $271.17. The company has a market cap of $97.83 billion, a PE ratio of 26.28, a P/E/G ratio of 5.67 and a beta of 0.41. CME Group Inc. has a one year low of $213.94 and a one year high of $290.79.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the previous year, the company posted $2.56 earnings per share. The company’s quarterly revenue was up 10.4% on a year-over-year basis. On average, equities research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were issued a dividend of $1.25 per share. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group’s dividend payout ratio is presently 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.